Inventor
VAKA SIVA RAM KIRAN
US34 patents
⚠️ This page may combine multiple inventors who share the name “VAKA SIVA RAM KIRAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMNEAL COMPLEX PRODUCTS RES LLC
11 patentsUS11166906B2Nov 9, 2021
Programmable pharmaceutical compositions for chrono drug release
AMNEAL COMPLEX PRODUCTS RES LLC3 citations83
US11684580B2Jun 27, 2023
Extended release compositions comprising trihexyphenidyl
AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11666536B2Jun 6, 2023
Extended release compositions comprising pyridostigmine
AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11464742B2Oct 11, 2022
Extended release compositions comprising trihexyphenidyl
AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11419813B2Aug 23, 2022
Programmable pharmaceutical compositions for chrono drug release
AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11318091B2May 3, 2022
Gastroretentive dosage forms for sustained drug delivery
AMNEAL COMPLEX PRODUCTS RES LLC1 citations71
US12233166B2Feb 25, 2025
Extended release compositions comprising pyridostigmine
AMNEAL COMPLEX PRODUCTS RES LLC0 citations62
US11911515B2Feb 27, 2024
Extended release compositions comprising pyridostigmine
AMNEAL COMPLEX PRODUCTS RES LLC0 citations62
US11439585B2Sep 13, 2022
Programmable pharmaceutical compositions for chrono drug release
AMNEAL COMPLEX PRODUCTS RES LLC0 citations61
US12042559B2Jul 23, 2024
Gastroretentive dosage forms for sustained drug delivery
AMNEAL COMPLEX PRODUCTS RES LLC0 citations59
US11547670B2Jan 10, 2023
Delayed release methylphenidate compositions
AMNEAL COMPLEX PRODUCTS RES LLC0 citations51
KASHIV SPECIALTY PHARMACEUTICALS LLC
11 patentsUS11000471B2May 11, 2021
Programmable pharmaceutical compositions for chrono drug release
KASHIV SPECIALTY PHARMACEUTICALS LLC3 citations83
US10980738B2Apr 20, 2021
Programmable pharmaceutical compositions for chrono drug release
KASHIV SPECIALTY PHARMACEUTICALS LLC5 citations83
US11478425B2Oct 25, 2022
Extended release compositions comprising pyridostigmine
KASHIV SPECIALTY PHARMACEUTICALS LLC2 citations73
US11154505B1Oct 26, 2021
Extended release compositions comprising trihexyphenidyl
KASHIV SPECIALTY PHARMACEUTICALS LLC3 citations73
US11045420B2Jun 29, 2021
Extended release compositions comprising trihexyphenidyl
KASHIV SPECIALTY PHARMACEUTICALS LLC4 citations73
US11040014B2Jun 22, 2021
Extended release compositions comprising trihexyphenidyl
KASHIV SPECIALTY PHARMACEUTICALS LLC4 citations73
US10925833B2Feb 23, 2021
Extended release compositions comprising pyridostigmine
KASHIV SPECIALTY PHARMACEUTICALS LLC2 citations73
US10881617B1Jan 5, 2021
Extended release compositions comprising pyridostigmine
KASHIV SPECIALTY PHARMACEUTICALS LLC2 citations73
US11154494B2Oct 26, 2021
Programmable pharmaceutical compositions for chrono drug release
KASHIV SPECIALTY PHARMACEUTICALS LLC1 citations72
US11007145B2May 18, 2021
Gastroretentive dosage forms for sustained drug delivery
KASHIV SPECIALTY PHARMACEUTICALS LLC1 citations71
US11564888B2Jan 31, 2023
Extended release compositions comprising trihexyphenidyl
KASHIV SPECIALTY PHARMACEUTICALS LLC0 citations62
KASHIV BIOSCIENCES LLC
10 patentsUS10869839B2Dec 22, 2020
Extended release compositions comprising trihexyphenidyl
KASHIV BIOSCIENCES LLC5 citations84
US10898431B2Jan 26, 2021
Programmable pharmaceutical compositions for chrono drug release
KASHIV BIOSCIENCES LLC8 citations83
US11229606B2Jan 25, 2022
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC1 citations73
US10987311B2Apr 27, 2021
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC2 citations73
US10744093B2Aug 18, 2020
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC2 citations73
US10588863B2Mar 17, 2020
Extended release compositions comprising pyridostigmine
KASHIV BIOSCIENCES LLC2 citations73
US10406234B2Sep 10, 2019
Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms
KASHIV BIOSCIENCES LLC2 citations73
US10857098B2Dec 8, 2020
Gastroretentive dosage forms for sustained drug delivery
KASHIV BIOSCIENCES LLC1 citations71
US10744131B2Aug 18, 2020
Abuse-resistant drug formulations
KASHIV BIOSCIENCES LLC0 citations40
US10632113B2Apr 28, 2020
Abuse-resistant drug formulations with built-in overdose protection
KASHIV BIOSCIENCES LLC0 citations40